Single-Use Bioprocessing Market to Reach $33.67 Billion by 2030 | Growth, Trends & Opportunities
The global single-use bioprocessing market is projected to grow from USD 18.01 billion in 2025 to USD 33.67 billion by 2030, registering a CAGR of 13.3% during the forecast period. This rapid expansion is driven by the increasing adoption of single-use technologies among CDMOs and CMOs, rising demand for cost-efficient production, reduced risk of cross-contamination, and lower capital investment requirements.
Market...
Mice Model Market to Reach $2.74 Billion by 2030
The global Mice Model Market is projected to grow from USD 1.70 billion in 2025 to USD 2.74 billion by 2030, registering a CAGR of 10.0% during the forecast period. Growth is being fueled by increasing reliance on mice models in preclinical research, rising adoption of mouse clinical trials (MCTs), and expanding applications in personalized medicine—particularly in oncology.
Download...
Nuclear Medicine Software Market: Powering the Next Generation of Precision Healthcare
The global healthcare industry is undergoing a major digital transformation, and nuclear medicine is at the center of this evolution. As hospitals and diagnostic centers increasingly adopt advanced imaging technologies and personalized treatment approaches, the demand for sophisticated nuclear medicine software solutions is accelerating rapidly.
According to recent market estimates, the global...
Nuclear Medicine Equipment Market Growth 2030: Theranostics, AI Imaging & Precision Medicine Driving the Future
The global nuclear medicine equipment market is on a steady growth trajectory, projected to reach USD 8.31 billion by 2030, up from USD 6.63 billion in 2025, expanding at a CAGR of 4.6% during the forecast period. This growth is largely fueled by the increasing burden of chronic diseases such as cancer and cardiovascular disorders, alongside the rising demand for early, accurate, and non-invasive...
Companion Diagnostics Market Poised for Robust Growth Through 2029
The global Companion Diagnostics Market is experiencing rapid expansion as precision medicine continues to reshape modern healthcare. According to industry projections, the market is expected to grow from USD 7.5 billion in 2024 to USD 13.6 billion by 2029, registering a CAGR of 12.6% during the forecast period. Companion diagnostics (CDx) have become an essential component in personalized medicine,...
Human Organoids Market to Reach $2.33 Billion by 2029
The global Human Organoids Market is gaining significant strategic traction as life sciences organizations accelerate the shift toward more predictive, ethical, and cost-efficient research models. Valued at USD 1.19 billion in 2024, the market is projected to reach USD 2.33 billion by 2029, growing at a CAGR of 14.4% during the forecast period. This growth underscores a critical transformation...
CRISPR Market Poised for Strong Growth as Gene Editing Applications Expand Across Healthcare and Agriculture
The global CRISPR Market is witnessing rapid expansion as gene editing technologies continue transforming healthcare, biotechnology, agriculture, and pharmaceutical research. According to recent industry analysis, the CRISPR market is projected to grow from USD 3.21 billion in 2025 to USD 5.47 billion by 2030, registering a CAGR of 11.2% during the forecast period.
The increasing demand for advanced...
Gene Therapy Market Set for Transformational Growth, Reaching USD 36.55 Billion by 2032
The global gene therapy market is undergoing a transformative evolution as healthcare systems increasingly shift toward precision medicine and curative therapies. According to recent industry analysis, the gene therapy market is projected to grow from USD 8.85 billion in 2024 to USD 36.55 billion by 2032, registering a robust CAGR of 19.4% during the forecast period. The rising burden of genetic disorders,...
Humanized Mouse and Rat Model Market: Accelerating Drug Discovery and Precision Medicine Growth
The global humanized mouse and rat model market is witnessing strong momentum, driven by the increasing complexity of drug discovery and the rising demand for personalized medicine. Valued at approximately USD 255.8 million in 2024, the market is projected to reach USD 409.8 million by 2030, expanding at a CAGR of 8.2%. This growth reflects the expanding role of advanced preclinical models in improving...